SMT201600084B - Sintesi del sale n4-(2,2-dimetil-4-[(diidrogeno fosfonossi)metil]-3-osso-5-pirido[1,4]ossazin-6-il)-5-fluoro-n2-(3,4,5-trimetossifenil)-2,4-pirimidindiammina disodio - Google Patents

Sintesi del sale n4-(2,2-dimetil-4-[(diidrogeno fosfonossi)metil]-3-osso-5-pirido[1,4]ossazin-6-il)-5-fluoro-n2-(3,4,5-trimetossifenil)-2,4-pirimidindiammina disodio

Info

Publication number
SMT201600084B
SMT201600084B SM201600084T SM201600084T SMT201600084B SM T201600084 B SMT201600084 B SM T201600084B SM 201600084 T SM201600084 T SM 201600084T SM 201600084 T SM201600084 T SM 201600084T SM T201600084 B SMT201600084 B SM T201600084B
Authority
SM
San Marino
Prior art keywords
trimethosphenyl
pyrimidindymmine
phosphonossi
ossazin
pyrid
Prior art date
Application number
SM201600084T
Other languages
English (en)
Italian (it)
Inventor
Karl-Heinz Giselbrecht
Michael Wolberg
Ulfried Felfer
Original Assignee
Rigel Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rigel Pharmaceuticals Inc filed Critical Rigel Pharmaceuticals Inc
Publication of SMT201600084B publication Critical patent/SMT201600084B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/091Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
SM201600084T 2009-07-02 2016-03-24 Sintesi del sale n4-(2,2-dimetil-4-[(diidrogeno fosfonossi)metil]-3-osso-5-pirido[1,4]ossazin-6-il)-5-fluoro-n2-(3,4,5-trimetossifenil)-2,4-pirimidindiammina disodio SMT201600084B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27007309P 2009-07-02 2009-07-02
PCT/US2010/040792 WO2011002999A1 (en) 2009-07-02 2010-07-01 Synthesis of n4- (2, 2-dimethyl-4- [ (dihydrogen phosphonoxy ] -3-oxo-5-pyrido [1, 4] oxazin-6-yl)-5-fluoro-n2- (3, 4, 5,-trimethoxyphenyl) -2, 4- pyrimidinediamine disodium salt

Publications (1)

Publication Number Publication Date
SMT201600084B true SMT201600084B (it) 2016-04-29

Family

ID=42937685

Family Applications (1)

Application Number Title Priority Date Filing Date
SM201600084T SMT201600084B (it) 2009-07-02 2016-03-24 Sintesi del sale n4-(2,2-dimetil-4-[(diidrogeno fosfonossi)metil]-3-osso-5-pirido[1,4]ossazin-6-il)-5-fluoro-n2-(3,4,5-trimetossifenil)-2,4-pirimidindiammina disodio

Country Status (21)

Country Link
US (3) US8299242B2 (de)
EP (1) EP2448950B1 (de)
JP (1) JP5739882B2 (de)
CN (1) CN102482305B (de)
AU (1) AU2010266213B2 (de)
BR (1) BRPI1011888A2 (de)
CA (1) CA2766801C (de)
CY (1) CY1117489T1 (de)
DK (1) DK2448950T3 (de)
EA (1) EA021657B1 (de)
ES (1) ES2565985T3 (de)
HR (1) HRP20160319T1 (de)
HU (1) HUE027212T2 (de)
ME (1) ME02388B (de)
PL (1) PL2448950T3 (de)
RS (1) RS54679B1 (de)
SG (1) SG176799A1 (de)
SI (1) SI2448950T1 (de)
SM (1) SMT201600084B (de)
UA (1) UA108077C2 (de)
WO (1) WO2011002999A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008009122A1 (en) 2006-07-20 2008-01-24 Affinium Pharmaceuticals, Inc. Acrylamide derivatives as fab i inhibitors
UA108077C2 (xx) 2009-07-02 2015-03-25 Синтез динатрієвої солі n4-(2,2-диметил-4-$(дигідрофосфонокси)метил]-3-оксо-5-піридо$1,4]оксазин-6-іл)-5-фтор-n2-(3,4,5-триметоксифеніл)-2,4-піримідиндіаміну
CA2790199A1 (en) * 2010-02-24 2011-09-01 Auspex Pharmaceuticals, Inc. Trimethoxyphenyl inhibitors of tyrosine kinase
WO2013014454A1 (en) 2011-07-28 2013-01-31 Astrazeneca Ab New (trimethoxyphenylamino)pyrimidinyl formulations
TWI526437B (zh) * 2011-09-09 2016-03-21 台灣神隆股份有限公司 卡巴他賽之結晶型
US8426450B1 (en) * 2011-11-29 2013-04-23 Helsinn Healthcare Sa Substituted 4-phenyl pyridines having anti-emetic effect
SMT201900411T1 (it) 2012-06-19 2019-09-09 Debiopharm Int Sa Derivati di profaramci di (e)-n-metil-n-((3-metilbenzofuran-2-il)metil -3-(7-osso-5,6,7,8-tetraidro-1,8-naftiridin-3-il)acrilammide
CN102746337B (zh) * 2012-06-21 2014-12-17 成都苑东药业有限公司 一种2,4-嘧啶二胺类化合物及其制备方法
US9145411B2 (en) 2012-08-02 2015-09-29 Asana Biosciences, Llc Substituted amino-pyrimidine derivatives
PT3083648T (pt) * 2013-12-20 2018-12-14 Rigel Pharmaceuticals Inc Processo farmacêutico e intermediários
SMT202000719T1 (it) 2016-02-26 2021-03-15 Debiopharm Int Sa Medicinale per il trattamento d’infezioni del piede diabetico
US20180065992A1 (en) 2016-09-08 2018-03-08 Glykon Technologies Group, Llc Monomeric bimetal hydroxycitric acid compounds and methods of making and using the same
WO2019070827A1 (en) * 2017-10-04 2019-04-11 Celgene Corporation PROCESSES FOR THE PREPARATION OF CIS-4 [2 - {(3S, 4R) -3-FLUOROOXAN-4-YL] AMINO) -8- (2,4,6-TRICHLOROANILINO) -9H-PURIN-9-YL] -1 -MÉTHYLCYCLOHEXANE-1-carboxamide
HUE062061T2 (hu) 2019-02-14 2023-09-28 Debiopharm Int Sa Afabicin készítmény, eljárás annak elõállítására
UA129222C2 (uk) 2019-06-14 2025-02-12 Дебіофарм Інтернешнл С.А. Лікарський засіб і його застосування для лікування бактеріальних інфекцій, пов'язаних з біоплівкою

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US303022A (en) 1884-08-05 Egg-beater
US324087A (en) 1885-08-11 Abel combs
TWI329105B (en) 2002-02-01 2010-08-21 Rigel Pharmaceuticals Inc 2,4-pyrimidinediamine compounds and their uses
US20040024716A1 (en) 2002-04-12 2004-02-05 James Malatesta Mail sorting processes and systems
RS51752B (sr) 2002-07-29 2011-12-31 Rigel Pharmaceuticals Metode tretiranja i prevencije autoimunih oboljenja jedinjenjima 2,4-pirimidindiamina
HRP20130602T1 (en) 2003-07-30 2013-07-31 Rigel Pharmaceuticals, Inc. 2,4-pyrimidinediamine compounds for use in the treatment or prevention of autoimmune diseases
US20060047135A1 (en) 2004-08-30 2006-03-02 Chadwick Scott T Process for preparing chloromethyl di-tert-butylphosphate
DE602006010979D1 (de) * 2005-01-19 2010-01-21 Rigel Pharmaceuticals Inc Prodrugs aus 2,4-pyrimidindiamin-verbindungen und ihre verwendungen
US20090114877A1 (en) * 2005-09-13 2009-05-07 Eisai R&D Management Co., Ltd. Composition Containing Stability-Improved Chloromethyl Phosphate Derivatve and Process for Producing Same
US8163902B2 (en) * 2006-11-21 2012-04-24 Rigel Pharmaceuticals, Inc. Prodrugs of 2,4-pyrimidinediamine compounds and their uses
UA108077C2 (xx) 2009-07-02 2015-03-25 Синтез динатрієвої солі n4-(2,2-диметил-4-$(дигідрофосфонокси)метил]-3-оксо-5-піридо$1,4]оксазин-6-іл)-5-фтор-n2-(3,4,5-триметоксифеніл)-2,4-піримідиндіаміну

Also Published As

Publication number Publication date
EA201270114A1 (ru) 2012-05-30
AU2010266213A1 (en) 2012-02-02
HK1169996A1 (zh) 2013-02-15
JP5739882B2 (ja) 2015-06-24
EP2448950B1 (de) 2016-01-13
HUE027212T2 (en) 2016-10-28
US20110003986A1 (en) 2011-01-06
US8691798B2 (en) 2014-04-08
US8481724B2 (en) 2013-07-09
PL2448950T3 (pl) 2016-06-30
WO2011002999A1 (en) 2011-01-06
US8299242B2 (en) 2012-10-30
HRP20160319T1 (hr) 2016-04-22
CA2766801C (en) 2018-03-13
BRPI1011888A2 (pt) 2016-04-12
EA021657B1 (ru) 2015-08-31
SG176799A1 (en) 2012-01-30
CN102482305A (zh) 2012-05-30
CA2766801A1 (en) 2011-01-06
SI2448950T1 (sl) 2016-05-31
AU2010266213B2 (en) 2015-06-18
EP2448950A1 (de) 2012-05-09
ME02388B (de) 2016-09-20
ES2565985T3 (es) 2016-04-08
DK2448950T3 (en) 2016-04-04
UA108077C2 (xx) 2015-03-25
US20130018185A1 (en) 2013-01-17
CN102482305B (zh) 2016-07-13
RS54679B1 (sr) 2016-08-31
JP2012532143A (ja) 2012-12-13
CY1117489T1 (el) 2017-04-26
US20130274499A1 (en) 2013-10-17

Similar Documents

Publication Publication Date Title
SMT201600084B (it) Sintesi del sale n4-(2,2-dimetil-4-[(diidrogeno fosfonossi)metil]-3-osso-5-pirido[1,4]ossazin-6-il)-5-fluoro-n2-(3,4,5-trimetossifenil)-2,4-pirimidindiammina disodio
FR17C1040I2 (fr) Derive antiviraux de 2,5-dibenzimidazol-5-yl-1-phenyl-pyrrolidine
HUE037412T2 (hu) Vetõmag-adagolóeszköz elrendezése mezõgazdasági gépen
EP2547271A4 (de) Dynamische knochenplatte
EP2376098A4 (de) Dipeptid-verknüpfte medizinische mittel
BRPI0922508A2 (pt) Análogos de nucleosídeo
ATE467426T1 (de) Dampfsterilisationssystem
HRP20150477T8 (hr) Postupci dobivanja derivata kinazolona
FI20085199L (fi) Esikammiojärjestely
EP2568880A4 (de) Tracking mit feldzuordnung
BRPI0817562A2 (pt) derivados de n-hidroxilsulfonamida como novos doadores de niltroxil fisiologicamente úteis
EP2258369A4 (de) Mit arzneistoff versetztes pflaster
EP2768531A4 (de) Mit meglumin stabilisierte etanercept-formulierungen
EP2265283A4 (de) Auristatin-arznei-linker-konjugate
ES2590905T8 (es) Inhibidores de la tirosina quinasa de Bruton
LT3447061T (lt) Farmacinė vaisto forma, apimanti 5-fluor-2'-deoksiuridinofosforamidato darinį, skirtą naudoti vėžio gydymui
EP2451274A4 (de) Pharmazeutische zusammensetzungen
EP2419097A4 (de) Pharmazeutische zusammensetzungen
BRPI0918064A2 (pt) distribuidor de substância
EP2311518A4 (de) Medizinisches instrument
BR112013015982A2 (pt) instrumento de cuidado oral.
EP2258421A4 (de) Medizinisches instrument
BRPI0910853A2 (pt) cápsula com abertura de ar
BR112013015975A2 (pt) instrumento de cuidado oral.
BRPI1013616A2 (pt) medições diretas de desacoplamento de pressão arterial